8-K: Mirion Technologies Reports Strong Q3 2026 Results
Quarterly Results
Mirion Technologies announced robust third quarter 2026 financial results, featuring a 24.5% revenue increase to $277.8 million and a 151.6% surge in GAAP net income.
Summary
- Mirion Technologies reported strong financial results for the third quarter ended September 30, 2026.
- Total revenues increased by 24.5% to $277.8 million, up from $223.1 million in the same period of 2025.
- GAAP net income saw a substantial increase of 151.6%, reaching $7.8 million compared to $3.1 million in Q3 2025.
- Adjusted EBITDA grew by 23.7% to $64.8 million from $52.4 million year-over-year.
- Third quarter orders, excluding acquisitions, increased by 62% to $340 million, driven by a 105% rise in nuclear power-related orders.
- Including acquisitions, total orders reached $386 million, an 85% increase.
- The company revised its full-year 2026 guidance upwards for revenue growth, organic revenue growth, Adjusted EBITDA, Adjusted Free Cash Flow, and Adjusted EPS.
Sentiment
Score: 8
Explanation: StockSavvy.ai views this as a positive report, with strong revenue growth, significant increases in net income and orders, and upward revisions to full-year guidance across key metrics.
Positives
- Revenue growth of 24.5% to $277.8 million in Q3 2026.
- GAAP net income increased by 151.6% to $7.8 million.
- Adjusted EBITDA increased by 23.7% to $64.8 million.
- Significant order growth of 62% (excluding acquisitions) and 85% (including acquisitions).
- Nuclear power-related orders saw a substantial 105% increase.
- Organic revenue growth of 6.5% in Q3, with expectations for mid-to-high teens growth in Q4.
- Adjusted free cash flow of $47 million in the quarter and $107 million year-to-date.
- Revised 2026 guidance shows increased revenue growth (24-25%), organic revenue growth (7-8%), and Adjusted Free Cash Flow ($170-$185 million).
Negatives
- Adjusted EPS remained flat at $0.12 compared to the prior year, though the current period calculation includes stock-based compensation expense.
- The company's balance sheet shows a decrease in cash and cash equivalents from $412.3 million to $408.7 million.
- Goodwill decreased from $1,872.4 million to $1,859.5 million, and intangible assets decreased from $606.3 million to $516.1 million.
Risks
- Significant factors could cause actual results to differ materially from forward-looking statements, including changes in domestic and foreign business, market, economic, financial, political, and legal conditions.
- Geopolitical instability, tariffs, sanctions, export controls, trade restrictions, and supply chain disruptions.
- Developments in government budgets, including potential reductions, sequestration, or delays.
- Risks related to public perception of nuclear radiation and technologies.
- Risks associated with cybersecurity, data security, and other security threats.
- Challenges in managing the supply chain and difficulties with third-party manufacturers.
- Risks related to the outcome of litigation, government and regulatory proceedings, investigations, and inquiries.
- Potential impact of health epidemics, pandemics, and similar outbreaks on business operations.
Future Outlook
The company has revised its full-year 2026 guidance upwards, projecting total revenue growth of approximately 24%-25%, organic revenue growth of approximately 7%-8%, Adjusted EBITDA of approximately $285 million $292 million, Adjusted Free Cash Flow of approximately $170 million $185 million, and Adjusted EPS of approximately $0.50 $0.54 per share.
Management Comments
- "Third quarter results showcase quarterly orders performance, an inflection in organic revenue growth, and a doubling of year-to-date adjusted free cash flow generation."
- "Orders continued to trend higher, up 62% excluding acquisitions, boosted by a 105% increase in nuclear power-related orders."
- "Organic revenue increased 6.5% in the third quarter and we expect mid-to-high teens growth in the fourth quarter."
- "Our business is benefiting from todays reinvestment in the existing nuclear reactor fleet."
- "We are updating our guidance to reflect increased visibility to full year performance."
Industry Context
StockSavvy.ai notes that Mirion's strong performance, particularly in nuclear power-related orders, aligns with a broader trend of increased investment in existing nuclear reactor fleets and the development of new nuclear technologies like small modular reactors.
Stakeholder Impact
- Shareholders: Positive impact due to strong financial performance and upward revision of guidance, potentially leading to increased stock value.
- Employees: Continued growth and investment in the company may lead to job security and opportunities.
- Customers: Continued investment in nuclear power and other key sectors suggests ongoing demand for Mirion's solutions.
- Suppliers: Increased order volume may lead to greater demand for raw materials and components.
Next Steps
- Host a conference call on October 28, 2026, to discuss financial results.
- Continue to capture opportunities from large-scale new builds and small modular reactors.
- Reduce net leverage to approximately 2.6x by year-end.
Key Dates
| Date | Description |
|---|---|
| 2025-09-30 | Prior year period for Q3 financial results comparison. |
| 2026-09-30 | Current period for Q3 financial results. |
| 2026-10-27 | Date of the press release announcing Q3 2026 financial results and the filing of Form 8-K. |
| 2026-10-28 | Date of the conference call to discuss financial results. |
| 2026-12-31 | Fiscal year-end for 2026 guidance. |
Recommendation
buyThe filing indicates strong top-line and bottom-line growth, significant order acceleration, and positive revisions to future guidance, particularly driven by the nuclear power sector. These factors suggest a favorable outlook and potential for continued stock appreciation.
Keywords
Radiation detection, Radiation measurement, Radiation monitoring, Nuclear power, Medical imaging, Defense, Research, Financial results
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.